Table 2.
Genotype and allele frequencies for eNOS G894T polymorphism in Sickle Cell Disease patients and controls.
| Frequencies |
P | ||
|---|---|---|---|
| Sickle Cell Disease patients (n=79) |
Controls (n=48) |
||
| Genotypes | |||
| GG vs GT+TT | 50.6% vs 49.4% | 39.6% vs 60.4% | 0.226 |
| TT vs GG+GT | 19.0% vs 81.0% | 12.5% vs 87.5% | 0.340 |
| Alleles | |||
| G vs T | 65.8% vs 34.2% | 63.6% vs 36.4% | 0.712 |